Roivant Sciences (ROIV) Interest Coverage Ratio Growth (1y) (2023 - 2024)
Powered by 
Analysis
Roivant Sciences (ROIV) Interest Coverage Ratio Growth (1y) (2023 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.55 Bn | 197.56 Bn | 7.24 Bn | 36.43% |
| 2 | Gilead Sciences | 181.17 Bn | 177.99 Bn | 6.22 Bn | -532.04% |
| 3 | Vertex Pharmaceuticals | 132.18 Bn | 124.33 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.50 Bn | 74.50 Bn | 3.93 Bn | -60.78% |
| 5 | Argenx Se | 61.66 Bn | 56.48 Bn | 1.37 Bn | 176.09% |
| 6 | Moderna | 54.61 Bn | 49.47 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.17 Bn | 30.86 Bn | 992.69 Mn | 1,170.12% |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.04 Bn | 30.04 Bn | 1.16 Mn | - |
| 10 | Insmed | 28.11 Bn | 26.95 Bn | 358.27 Mn | 99.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 75.40% |
| Dec 31, 2023 | 482.76% |
| Sep 30, 2023 | 31.33% |
| Jun 30, 2023 | 71.30% |